CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 22 enrolled
Drug / intervention
Liothyronine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03098433
NCT03098433Phase 2Completed
CompareCT.gov

Effects of Liothyronine on Energy Expenditure and Cardiovascular Function

Virginia Commonwealth University·interventional·Posted Mar 31, 2017·Updated Mar 26, 2021

In Brief

A Phase 2 clinical trial evaluating Liothyronine, Levothyroxine, and 1 other intervention for Healthy. Completed, enrolled 22 participants across 1 site.

Detailed Summary

This study will assess the short term effects of a single dose of liothyronine on the cardiovascular system and energy expenditure

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedMar 31, 2017
Enrollment StartOct 20, 2017
Primary CompletionJun 24, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.3 years ago

Interventions

Liothyroninedrug

Single dose

Levothyroxinedrug

Active comparator

Placebosdrug

Placebo